The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Reports DescriptionAccording to the analysis conducted by Custom Market Insights (CMI), the Ultomiris drug market is ...

Aurinia Pharmaceuticals Inc. has announced positive results from a Phase 1 single-ascending-dose (SAD) study of aritinercept (AUR200), its dual inhibitor of B cell-activating factor (BAFF) and a ...